1. Pink Sheet
  2. >>Geography
  3. >>International

UNICEF Strikes Deal To Buy Russia’s Sputnik V Vaccine

Supply Will Depend On Emergency Use Listing By The WHO

 
• By Ian Schofield

A new procurement deal will add to the rollout of COVID-19 vaccines at global level. However, the leaders of the COVAX Facility say that by the end of June they will face a shortfall of 190 million doses, mainly because of the crisis in India, and are calling on wealthier countries to increase their donations.

Hand on blue surgery glove extracting Covid vaccine from vial with a syringe. In the background Unicef organization
UNICEF buys COVID-19 vaccines on behalf of the COVAX Facility • Source: Alamy

In a move that could signal the entry of Russia’s Sputnik V vaccine into global procurement schemes for the first time, UNICEF and the Russian Direct Investment Fund have signed a long-term agreement (LTA) for the supply of up to 220 million doses of the vaccine.

Procurement of Sputnik V under the LTA, which was signed with the RDIF’s wholly owned subsidiary, Human Vaccines LLC, is conditional on the vaccine receiving an emergency use listing (EUL) from the World Health Organization to confirm its

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography

International Group Aims To Shape The Inevitable Future Of AI In Pharmacovigilance

 
• By Urtė Fultinavičiūtė

Pharmacovigilance is a perfect rule-based and manual work-intensive playground for experimenting with AI. While some off-patent drug firms are already exploring new automation tools, regulation is lagging behind, leaving a gap for uncertainty.

Global Pharma Guidance Tracker - April 2025

 
• By Vibha Sharma and Anabel Costa-Ferreira

Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Medicare Negotiation Does Not Violate Due Process, Appeals Court Rules, Other Suits At Risk

 
• By Cathy Kelly

Decision in AstraZeneca’s lawsuit against the Health and Human Services Department is a precedent-setting victory for the government and a blow to manufacturer efforts to block the price negotiation program.